GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | September 04, 2024 |
PDB ID | UniProt ID | Title | Descriptor ▼ |
---|---|---|---|
6UM6 | A0A1W6IPB2 | Cryo-EM structure of HIV-1 neutralizing antibody DH270.6 in complex with CH848 10.17DT Env | Envelope glycoprotein gp120, DH270.6 Fab, Envelope glycoprotein gp41 |
6UM6 | Q2N0S7 | Cryo-EM structure of HIV-1 neutralizing antibody DH270.6 in complex with CH848 10.17DT Env | Envelope glycoprotein gp120, DH270.6 Fab, Envelope glycoprotein gp41 |
6UM6 | 6UM6 | Cryo-EM structure of HIV-1 neutralizing antibody DH270.6 in complex with CH848 10.17DT Env | Envelope glycoprotein gp120, DH270.6 Fab, Envelope glycoprotein gp41 |
6N1W | Q2N0S6 | Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody DFPH-a.15 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 | Envelope glycoprotein gp120, DFPH-a.15 heavy chain, DFPH-a.15 Light chain, Envelope glycoprotein gp41, PGT122 Light chain, PGT122 Heavy chain, VRC03 Light chain, VRC03 Heavy chain |
6N1W | 6N1W | Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody DFPH-a.15 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 | Envelope glycoprotein gp120, DFPH-a.15 heavy chain, DFPH-a.15 Light chain, Envelope glycoprotein gp41, PGT122 Light chain, PGT122 Heavy chain, VRC03 Light chain, VRC03 Heavy chain |
6N1W | Q2N0S7 | Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody DFPH-a.15 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 | Envelope glycoprotein gp120, DFPH-a.15 heavy chain, DFPH-a.15 Light chain, Envelope glycoprotein gp41, PGT122 Light chain, PGT122 Heavy chain, VRC03 Light chain, VRC03 Heavy chain |
6VLR | Q2N0S6 | BG505 SOSIP.v5.2 in complex with rhesus macaque Fab RM20E1 and PGT122 Fab | Envelope glycoprotein gp120, BG505 SOSIPv5.2 gp41, PGT122 Fab Heavy Chain, PGT122 Fab Light Chain, RM20E1 Fab Heavy Chain, RM20E1 Fab Kappa Chain |
6VLR | 6VLR | BG505 SOSIP.v5.2 in complex with rhesus macaque Fab RM20E1 and PGT122 Fab | Envelope glycoprotein gp120, BG505 SOSIPv5.2 gp41, PGT122 Fab Heavy Chain, PGT122 Fab Light Chain, RM20E1 Fab Heavy Chain, RM20E1 Fab Kappa Chain |
5VOC | Q6SW67 | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD | Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein |
5VOC | Q68674 | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD | Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein |
5VOC | P16837 | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD | Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein |
5VOC | F5HCP3 | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD | Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein |
5VOC | F5HET4 | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD | Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein |
5VOC | S6B291 | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD | Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein |
5VOC | 5VOC | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD | Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein |
5VOC | S6B291 | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD | Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein |
5VOC | 5VOC | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD | Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein |
5VOC | Q6GMX0 | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD | Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein |
5VOC | Q6GMX0 | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD | Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein |
5VOB | Q6SW67 | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 | Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein |
5VOB | Q68674 | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 | Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein |
5VOB | P16837 | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 | Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein |
5VOB | F5HCP3 | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 | Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein |
5VOB | F5HET4 | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 | Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein |
5VOB | S6B291 | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 | Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein |
5VOB | 5VOB | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 | Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein |
5VOB | S6B291 | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 | Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein |
5VOB | 5VOB | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 | Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein |
5VOB | Q6GMX0 | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 | Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein |
5VOB | Q6GMX0 | Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 | Envelope glycoprotein H, Envelope glycoprotein L, protein UL128, Envelope glycoprotein UL130, Protein UL131A, Fab 8I21 heavy chain,IgG H chain, Fab 8I21 light chain,Uncharacterized protein |
5T1D | P03231 | Crystal structure of EBV gHgL/gp42/E1D1 complex | Envelope glycoprotein H, Envelope glycoprotein L, Glycoprotein 42, E1D1 IgG2a heavy chain, E1D1 IgG2a light chain |
5T1D | P03212 | Crystal structure of EBV gHgL/gp42/E1D1 complex | Envelope glycoprotein H, Envelope glycoprotein L, Glycoprotein 42, E1D1 IgG2a heavy chain, E1D1 IgG2a light chain |
5T1D | P0C6Z5 | Crystal structure of EBV gHgL/gp42/E1D1 complex | Envelope glycoprotein H, Envelope glycoprotein L, Glycoprotein 42, E1D1 IgG2a heavy chain, E1D1 IgG2a light chain |
5T1D | 5T1D | Crystal structure of EBV gHgL/gp42/E1D1 complex | Envelope glycoprotein H, Envelope glycoprotein L, Glycoprotein 42, E1D1 IgG2a heavy chain, E1D1 IgG2a light chain |
6C5V | K9US75 | An anti-gH/gL antibody that neutralizes dual-tropic infection defines a site of vulnerability on Epstein-Barr virus | Envelope glycoprotein H, Envelope glycoprotein L, Glycoprotein 42, Antibody Fab AMMO1 heavy chain, Antibody Fab AMMO1 light chain |
6C5V | Q1HVF6 | An anti-gH/gL antibody that neutralizes dual-tropic infection defines a site of vulnerability on Epstein-Barr virus | Envelope glycoprotein H, Envelope glycoprotein L, Glycoprotein 42, Antibody Fab AMMO1 heavy chain, Antibody Fab AMMO1 light chain |
6C5V | P0C6Z5 | An anti-gH/gL antibody that neutralizes dual-tropic infection defines a site of vulnerability on Epstein-Barr virus | Envelope glycoprotein H, Envelope glycoprotein L, Glycoprotein 42, Antibody Fab AMMO1 heavy chain, Antibody Fab AMMO1 light chain |
6C5V | 6C5V | An anti-gH/gL antibody that neutralizes dual-tropic infection defines a site of vulnerability on Epstein-Barr virus | Envelope glycoprotein H, Envelope glycoprotein L, Glycoprotein 42, Antibody Fab AMMO1 heavy chain, Antibody Fab AMMO1 light chain |
7LBG | Q6SW67 | CryoEM structure of the HCMV Trimer gHgLgO in complex with human Transforming growth factor beta receptor type 3 and neutralizing fabs 13H11 and MSL-109 | Envelope glycoprotein H, Envelope glycoprotein L, Envelope glycoprotein O, Transforming growth factor beta receptor type 3, Fab 13H11 light chain, Fab 13H11 heavy chain, Fab Msl-109 light chain, Fab Msl-109 heavy chain |
7LBG | F5HCH8 | CryoEM structure of the HCMV Trimer gHgLgO in complex with human Transforming growth factor beta receptor type 3 and neutralizing fabs 13H11 and MSL-109 | Envelope glycoprotein H, Envelope glycoprotein L, Envelope glycoprotein O, Transforming growth factor beta receptor type 3, Fab 13H11 light chain, Fab 13H11 heavy chain, Fab Msl-109 light chain, Fab Msl-109 heavy chain |
7LBG | Q8BCU3 | CryoEM structure of the HCMV Trimer gHgLgO in complex with human Transforming growth factor beta receptor type 3 and neutralizing fabs 13H11 and MSL-109 | Envelope glycoprotein H, Envelope glycoprotein L, Envelope glycoprotein O, Transforming growth factor beta receptor type 3, Fab 13H11 light chain, Fab 13H11 heavy chain, Fab Msl-109 light chain, Fab Msl-109 heavy chain |
7LBG | Q03167 | CryoEM structure of the HCMV Trimer gHgLgO in complex with human Transforming growth factor beta receptor type 3 and neutralizing fabs 13H11 and MSL-109 | Envelope glycoprotein H, Envelope glycoprotein L, Envelope glycoprotein O, Transforming growth factor beta receptor type 3, Fab 13H11 light chain, Fab 13H11 heavy chain, Fab Msl-109 light chain, Fab Msl-109 heavy chain |
7LBG | 7LBG | CryoEM structure of the HCMV Trimer gHgLgO in complex with human Transforming growth factor beta receptor type 3 and neutralizing fabs 13H11 and MSL-109 | Envelope glycoprotein H, Envelope glycoprotein L, Envelope glycoprotein O, Transforming growth factor beta receptor type 3, Fab 13H11 light chain, Fab 13H11 heavy chain, Fab Msl-109 light chain, Fab Msl-109 heavy chain |
7LBF | Q6SW67 | CryoEM structure of the HCMV Trimer gHgLgO in complex with human Platelet-derived growth factor receptor alpha and neutralizing fabs 13H11 and MSL-109 | Envelope glycoprotein H, Envelope glycoprotein L, Envelope glycoprotein O, Isoform 3 of Platelet-derived growth factor receptor alpha (E.C.2.7.10.1), Fab 13H11 light chain, Fab 13H11 heavy chain, Fab Msl-109 light chain, Fab Msl-109 heavy chain |
7LBF | F5HCH8 | CryoEM structure of the HCMV Trimer gHgLgO in complex with human Platelet-derived growth factor receptor alpha and neutralizing fabs 13H11 and MSL-109 | Envelope glycoprotein H, Envelope glycoprotein L, Envelope glycoprotein O, Isoform 3 of Platelet-derived growth factor receptor alpha (E.C.2.7.10.1), Fab 13H11 light chain, Fab 13H11 heavy chain, Fab Msl-109 light chain, Fab Msl-109 heavy chain |
7LBF | Q8BCU3 | CryoEM structure of the HCMV Trimer gHgLgO in complex with human Platelet-derived growth factor receptor alpha and neutralizing fabs 13H11 and MSL-109 | Envelope glycoprotein H, Envelope glycoprotein L, Envelope glycoprotein O, Isoform 3 of Platelet-derived growth factor receptor alpha (E.C.2.7.10.1), Fab 13H11 light chain, Fab 13H11 heavy chain, Fab Msl-109 light chain, Fab Msl-109 heavy chain |
7LBF | P16234 | CryoEM structure of the HCMV Trimer gHgLgO in complex with human Platelet-derived growth factor receptor alpha and neutralizing fabs 13H11 and MSL-109 | Envelope glycoprotein H, Envelope glycoprotein L, Envelope glycoprotein O, Isoform 3 of Platelet-derived growth factor receptor alpha (E.C.2.7.10.1), Fab 13H11 light chain, Fab 13H11 heavy chain, Fab Msl-109 light chain, Fab Msl-109 heavy chain |
7LBF | 7LBF | CryoEM structure of the HCMV Trimer gHgLgO in complex with human Platelet-derived growth factor receptor alpha and neutralizing fabs 13H11 and MSL-109 | Envelope glycoprotein H, Envelope glycoprotein L, Envelope glycoprotein O, Isoform 3 of Platelet-derived growth factor receptor alpha (E.C.2.7.10.1), Fab 13H11 light chain, Fab 13H11 heavy chain, Fab Msl-109 light chain, Fab Msl-109 heavy chain |
7LBE | Q6SW67 | CryoEM structure of the HCMV Trimer gHgLgO in complex with neutralizing fabs 13H11 and MSL-109 | Envelope glycoprotein H, Envelope glycoprotein L, Envelope glycoprotein O, Fab 13H11 light chain, Fab 13H11 heavy chain, Fab Msl-109 light chain, Fab Msl-109 heavy chain |
7LBE | F5HCH8 | CryoEM structure of the HCMV Trimer gHgLgO in complex with neutralizing fabs 13H11 and MSL-109 | Envelope glycoprotein H, Envelope glycoprotein L, Envelope glycoprotein O, Fab 13H11 light chain, Fab 13H11 heavy chain, Fab Msl-109 light chain, Fab Msl-109 heavy chain |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024